There were 1,107 press releases posted in the last 24 hours and 400,766 in the last 365 days.

Cardiac Mapping Market Report 2020: Industry Size to 2024, Market Dynamics, Lucrative Segments, Competitive Landscape, Key Player Profiles

Dublin, Jan. 23, 2020 (GLOBE NEWSWIRE) -- The "Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecast to 2024" report has been added to's offering.

The global cardiac mapping market size is projected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019 at a CAGR of 8.7%.

The emergence of new entrants, growing investments, funds, and grants, increasing incidences of target diseases, and growth in the geriatric population are supporting the growth of this market. However, unfavorable healthcare reforms in the US and the lack of skilled & experienced electrophysiologists may restrain the market to a certain extent during the forecast period.

The major players in the cardiac mapping market include Biosense Webster (US), Abbott (US), Medtronic (Ireland), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).

The contact cardiac mapping segment is projected to dominate the cardiac mapping products market during the forecast period.

The cardiac mapping products market has been segmented into contact with cardiac mapping systems and non-contact cardiac mapping systems. The contact cardiac mapping systems segment further includes electroanatomical mapping, basket catheter mapping, and traditional endocardial mapping. The contact cardiac mapping systems segment held the largest share of this market in 2018 and is also estimated to grow at the highest CAGR during the forecast period. Contact mapping systems are technologically more efficient and precise, hence, they provide higher accuracy, sensitivity, and efficiency in disease diagnosis and ablation.

The atrial fibrillation applications segment held the largest market share in 2018.

By indication, the cardiac mapping market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias. The atrial fibrillation segment accounted for the largest share of this market in 2018. The large share of this segment can be attributed to the technological advancements in mapping systems and the rising incidences of AF and associated ablation procedures.

The North American cardiac mapping market is expected to hold the largest share during the forecast period.

Geographically, the cardiac mapping industry is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. North America is expected to hold the largest share of this market during the forecast period. The increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, and growing focus of government organizations on providing funding for cardiological research are the key factors driving the North American market.

Key Topics Covered

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Market Overview
4.2 Geographic Analysis: European Cardiac Mappingmarket, By Indication & Country (2019)
4.3 Market Share, By Type, 2019 vs. 2024
4.4 Market Share, By Indication, 2019 vs. 2024
4.5 Geographic Outlook: Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers New Entrants in the Market Growing Investments, Funds, and Grants Increasing Incidence of Target Diseases Growth in the Geriatric Population
5.2.2 Restraints Unfavorable Healthcare Reforms in the US Lack of Skilled and Experienced Electrophysiologists
5.2.3 Opportunities Emerging Markets Technological Advancements
5.2.4 Challenges Unfavorable Regulatory Scenario Alternative Technologies

6 Cardiac Mapping Market, By Type
6.1 Introduction
6.2 Contact Cardiac Mapping Systems
6.2.1 Electroanatomical Mapping Systems Electroanatomical Mapping Systems Account for the Largest Share of the Contact Mapping Systems Market
6.2.2 Basket Catheter Mapping Systems Basket Catheter Mapping Systems Provide Simultaneous, Multiple, Stable Recordings for Most Endocardial Surfaces - A Key Factor Driving Market Growth
6.2.3 Traditional Endocardial Catheter Mapping Systems Exposure to Ionizing Radiation Due to the Need for Fluoroscopy Guidance is A Key Disadvantage of Traditional Endocardial Catheter Mapping Systems
6.3 Non-Contact Cardiac Mapping Systems
6.3.1 Non-Contact Mapping is Applicable in Cases Where the Arrhythmia Cannot Be Tolerated Or in Cases Where Clinical Arrhythmia is Not Reproducible During the Electrophysiology Study

7 Cardiac Mapping Market, By Indication
7.1 Introduction
7.2 Atrial Fibrillation
7.2.1 Growing Number of Cases of Atrial Fibrillation and the Subsequent Increase in the Number of Ablation Procedures to Drive Market Growth
7.3 Atrial Flutter
7.3.1 High Success Rate of Radiofrequency Catheter Ablation for the Treatment of Atrial Flutter is A Major Factor Contributing to the Growth of This Market
7.4 Atrioventricular Nodal Reentry Tachycardia (Avnrt)
7.4.1 Growing Number of Avnrt Cases Across the Globe is Supporting the Growth of This Segment
7.5 Other Arrhythmias

8 Cardiac Mapping Market, By Region
8.1 Introduction
8.2 North America
8.2.1 US High Burden of Cvds to Drive the Demand for Cardiac Mapping in the US
8.2.2 Canada Growing Focus of Government Organizations on Providing Research Funding to Support Market Growth in Canada
8.3 Europe
8.3.1 Germany Favorable Healthcare Expenditure and Growing Use of Crt Devices to Drive Market Growth
8.3.2 UK Rising Geriatric Population to Support Market Growth
8.3.3 France Increasing Incidence of Heart Failure to Support Market Growth
8.3.4 Italy Increasing Incidence of Cvd to Drive the Adoption of Cardiac Mapping Systems
8.3.5 Spain Increasing Cardiac Ablation Procedures to Drive the Market in Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan Favourable Reimbursement Scenario to Support Market Growth
8.4.2 China Growing Geriatric Population to Drive the Market for Cardiac Mapping Systems
8.4.3 India Increasing Government Initiatives Towards Healthcare are Supporting the Growth of the Market in India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World

9 Competitive Landscape
9.1 Introduction
9.2 Market Ranking Analysis
9.3 Competitive Leadership Mapping (Overall Market)
9.3.1 Visionary Leaders
9.3.2 Innovators
9.3.3 Emerging Companies
9.3.4 Dynamic Differentiators
9.4 Competitive Scenario
9.4.1 Product Launches & Approvals
9.4.2 Partnerships, Agreements, and Collaborations
9.4.3 Acquisitions

10 Company Profile
10.1 Biosense Webster, Inc. (A Johnson & Johnson Company)
10.2 Abbott Laboratories
10.3 Medtronic PLC
10.4 Boston Scientific Corporation
10.5 Microport Scientific Corporation
10.6 EP Solutions S.A.
10.7 Acutus Medical
10.8 Koninklijke Philips N.V.
10.9 Lepu Medical
10.1 Biotronik
10.11 Angiodynamics
10.12 Biosig Technologies, Inc.
10.13 APN Health, LLC
10.14 Coremap
10.15 Kardium, Inc.
10.16 Catheter Precision, Inc.
10.17 Epmap-System

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Primary Logo